QIBA Musculoskeletal (MSK) Biomarker Committee (BC) Meeting Summary - July 25, 2023

Aug 27, 2026

Upload by Miles

Meeting summary for the QIBA Musculoskeletal (MSK) Biomarker Committee (BC) held on Tuesday, July 25, 2023 at 10 a.m. CT. Covers updates on Calimetrix MSK phantom manufacturing, the QIBA transition plan toward RSNA Quantitative Imaging Committee (QUIC), and Stage 3/4 Conformance Site Testing, including data transfer process details and Ambra image-uploading timelines. Lists action items for phantom delivery, next-step coordination, DOA template drafting, and upcoming August 22 meeting planning.

LanguageEnglish

CategoryResearch & Report

FormatPDF

Pages2

Reading Time5 min

AccessFree to download

Topics Discussed

Action Items

Stage 3 & 4 Conformance Testing Update

Next Steps

QIBA Musculoskeletal (MSK) Biomarker Committee (BC) Meeting Tuesday, July 25, 2023, at 10 a.m. CT Meeting Summary In attendance Xiaojuan Li, PhD (Co-chair) Thomas Link, MD, PhD (Co-Chair) Donald Anderson, PhD Michael Boss, PhD Angie Botto-van Bemden, PhD Jean H. Brittain, PhD Majid Chalian, MD Jonathan Doyle, MCS Natália Favoreto, MS… José Garcia, BS Shivraman Giri, PhD Peter Hardy, PhD Gabby Joseph, PhD Youngkyoo Jung, PhD… Jason Kim, PhD Mei Li, MD Jing Liu, PhD Kecheng Liu, PhD, MBA Nancy Obuchowski, PhD Chris Peng, PhD Atefe Pooyan, MD, MPH David Rutkowski, PhD Rianne van der Heijden, MD, PhD Gudrun Zahlmann, PhD Yansong Zhao, PhD RSNA Joe Koudelik Susan Stanfa Topics Discussed • Update on Calimetrix MSK phantom manufacturing timeline (Dr. Brittain) • QIBA transition update (Dr. Chalian) • RSNA QIBA MSK Profile Stage 3 and 4 Conformance Site Testing Updates (Dr. Li) Action Items Calimetrix MSK phantom manufacturing update (Drs. Brittain and Rutkowski) • The phantom was tested, shipped, and arrived at the Cleveland Clinic (CC) on July 25 • The instruction manual was sent to the CC and can be requested from Drs. Brittain and Rutkowski QIBA transition update and MSKBC next steps (Dr. Chalian) • Feasible BC deliverables to be determined, as QIBA admin support and BCs will be dissolved in ~5 months • Once formed, the new RSNA Quantitative Imaging Committee (QUIC) may initially focus on 1-3 QIBs; QUIC will reach out to BCs • In-process Profiles to advance to nearest stage and/or summary / white paper of the Profile to be published • QIBA brand to remain following the dissolution of the current structure; QUIC to determine process for approval of QIBA Profiles in 2024 and beyond • QIBA Wiki will be accessible post-transition • Comments / questions about transition plans to be submitted via Future Direction of QIBA Activities Form • Possible natural partnerships with societies, e.g., ISMRM, ASFNR, [etc. to](etc. to) be considered • Progress to continue on MSK combined stage 3/4 Profile work, e.g., data collection and analysis, until and after RSNA admin support ceases o Multisite comparison to follow is estimated to take 1 – 2 years Stage 3 & 4 Conformance Testing Update • The May 23, 2023, MSK BC Call Summary contains data transfer process details • Ambra presentation can be accessed at: [https://rsna](https://rsna) [org.zoom.us/rec/share/BUlkT2cJNazP2O4cmzkjajCd1yWwZsTymT9ZEw2jnjmz87ouR8DLV6f2I0rPY1A3._Zc2Y](org.zoom.us/rec/share/BUlkT2cJNazP2O4cmzkjajCd1yWwZsTymT9ZEw2jnjmz87ouR8DLV6f2I0rPY1A3._Zc2Y)[ ](org.zoom.us/rec/share/BUlkT2cJNazP2O4cmzkjajCd1yWwZsTymT9ZEw2jnjmz87ouR8DLV6f2I0rPY1A3._Zc2Y)[Wujqi0paWtn](Wujqi0paWtn | Passcode: VW9@K)[ | Passcode: VW9@K](Wujqi0paWtn | Passcode: VW9@K)* [.A](.A) • Ambra to release image uploading protocol on July 26 • In order to provide data/image access to Arthritis Foundation DOA (Document of Agreement) is needed between Arthritis Foundation and all sites which should be similar for all sites, a template document should be used • Initial QIBA scans have been performed at some sites (e.g., UCSF) Next Steps • Email address of person uploading data should be sent to Dr. Mei Li, who will send compiled email addresses and site numbers to Ambra for account creation o Link will then be provided to site contacts who will generate account and password to upload data o Drs. Xiaojuan Li and Mei Li can be contacted with data transfer questions or issues • Dr. Chalian to draft a common DOA template for all sites to use • Next meeting: Tuesday, August 22, 2023, at 10 a.m. CT Participants are welcome to contact RSNA staff at [qiba@rsna.org](qiba@rsna.org) if their attendance is not reflected on meeting summaries.

FAQs

What updates were provided on Calimetrix MSK phantom manufacturing?

The phantom was tested, shipped, and arrived at the Cleveland Clinic (CC) on July 25. The instruction manual was sent to CC and can be requested from the committee leads.

What is the QIBA transition plan and how does it affect MSKBC next steps?

Feasible BC deliverables will be determined as QIBA admin support and BCs are expected to be dissolved in about five months. After formation, RSNA QUIC may initially focus on 1–3 QIBs and will reach out to BCs, with progression guidance for profiles and continued work through and after the transition.

What were the main points of the Stage 3 & 4 conformance testing update?

The May 23, 2023 MSK BC call summary includes data transfer process details, and an Ambra presentation is referenced for access. Ambra will release the image-uploading protocol on July 26, and a DOA template is required for Arthritis Foundation data access across sites.

Aug 27, 2026

Upload by Miles